Table 2.
Study Design | Authors | Natural Infection or Postimmunization | Endpoint | Correlates of Protection Identified |
---|---|---|---|---|
Passive immunity | Weinreich et al,47 2021 Chen et al,48 2021 |
Passive antibody transfer | SARS-CoV-2 viral load | nAb, no specific threshold determined |
Animal model | McMahan et al,50 2021 | Natural infection | SARS-CoV-2 PCR detection in BAL | 50 for pseudovirus nAb titers; 100 for RBD ELISA titers; 400 for S ELISA titers |
Animal model | Corbett et al,52 2020 | Postimmunization | SARS-CoV-2 PCR detection in BAL | nAb, no specific threshold determined |
Animal model | Mercado et al,51 2020 | Postimmunization | SARS-CoV-2 PCR detection in BAL | nAb 100–250 |
Cohort study | Addetia et al,58 2020 | Natural infection | SARS-CoV-2 PCR (nasopharyngeal) and clinical symptoms | nAb were protective in 3 crew members with levels of 1:174, 1:161, and 1:3082 |